Key findings:

• Eleven types of cancer are increasing in individuals aged 20 to 49 in England.
• Obesity is identified as a major driver behind these rising cancer rates.
• The cancers linked to obesity include thyroid, multiple myeloma, liver, kidney, gallbladder, colorectal, pancreatic, endometrial, oral, breast, and ovarian cancers.
• Bowel cancer rates in younger women linked to BMI rose from 0.9 to 1.6 per 100,000 people.
• Approximately 31,000 cancers were diagnosed in people aged 20 to 49 in England in 2023.

Research shows that for nine of the eleven cancers, incidence rates are increasing among both younger and older adults. Smoking rates among younger adults have fallen by about two percent annually over the last two decades. In contrast, obesity-related cancers are on the rise. Professor Montserrat García‑Closas stated that the trends are unlikely to be explained by changes in most known behavioral risk factors.

Professor Kristian Helin emphasized the need for stronger public health policies to tackle obesity across all ages. He noted that addressing this issue could slow the rise in cancer cases and prevent many cancers from developing. However, officials have not confirmed what specific interventions will be implemented.

Despite these increases, cancer remains a rare disease among young people. Professor Amy Berrington pointed out that while rates have been increasing, it still affects a small portion of this demographic. The exact causes behind this rise remain unclear and require further research.

The post 11 cancers young people appeared first on News Casino.

Leonid Radvinsky, a prominent figure in the adult entertainment industry, has died of cancer at the age of 43. Radvinsky was best known as the owner of OnlyFans, a subscription-based platform that has transformed how adult film actors and sex workers monetize their content. His passing marks a significant moment for the industry, which has seen substantial growth under his leadership.

Radvinsky acquired Fenix International Limited, the parent company of OnlyFans, in 2018, and since then, he has played a crucial role in the platform’s development. As a Ukrainian-American billionaire, he had a net worth of approximately $3.8 billion as of May 2025. His influence extended beyond financial success; he was also known for his philanthropic efforts, including a $23 million grant program for cancer research projects established with his wife in 2024.

OnlyFans was founded in 2016 by British entrepreneur Tim Stokely, and under Radvinsky’s ownership, it has grown to host around 4.6 million creators and 377 million subscribers by 2024. The platform’s annual revenue reached $6.6 billion, showcasing its significant impact on the adult entertainment market. Radvinsky’s total dividends from OnlyFans have approached nearly $2 billion since his acquisition, reflecting the platform’s lucrative nature.

In a statement, a spokesperson for OnlyFans expressed deep sorrow over Radvinsky’s passing, saying, “We are deeply saddened to announce the death of Leo Radvinsky. Leo passed away peacefully after a long battle with cancer.” The spokesperson also noted that Radvinsky’s family has requested privacy during this difficult time.

Prior to his success with OnlyFans, Radvinsky began his career by running pornography sites as a teenager. In 2009, he founded a venture capital fund named Leo, focusing primarily on investments in technology companies. His entrepreneurial spirit and innovative approach have left a lasting legacy in the industry.

As Radvinsky’s death reverberates through the adult entertainment community, observers are left to ponder the future of OnlyFans and its direction without its majority shareholder and director. The platform has been exploring a potential sale of a 60% stake, which could have significant implications for its operations and strategy moving forward.

Industry experts anticipate that the leadership transition may lead to changes in how OnlyFans operates, particularly in its approach to creator support and content monetization. While the immediate future remains uncertain, Radvinsky’s contributions to the adult entertainment landscape will not be forgotten, and his impact will continue to influence the industry for years to come.

The post Leonid Radvinsky: A Legacy in the Adult Entertainment Industry appeared first on News Casino.

“As many of you know, Stephanie meant the world to Jeff,” announced Jeff Nippard on Instagram, following the unexpected death of his fiancée, Stephanie Buttermore, at the age of 36 on March 6, 2026. The news has left her followers and the scientific community in shock, as her contributions to both fitness and cancer research were significant.

Buttermore, who held a PhD in Pathology and Cell Biology, was known for her groundbreaking research in ovarian cancer detection and early screening. She discovered a protein called RHAMM, which has potential as an early screening marker for ovarian cancer. Her academic achievements were complemented by her role as a fitness influencer, where she blended her scientific knowledge with her passion for fitness, educating over 525,000 followers on Instagram and more than 1.17 million subscribers on YouTube.

Despite her success, Buttermore faced personal challenges. In May 2024, she stepped away from social media due to severe anxiety, a struggle she had openly discussed with her audience. However, she had expressed optimism about her mental health, stating, “My mental health has been the best it’s ever been, and I’m way more present.” This statement reflected her journey towards healing and self-acceptance.

Her last public appearance was on February 14, 2026, alongside Nippard, where they celebrated their engagement, which had taken place in October 2022. Just days before her passing, she shared a heartfelt message on Instagram, writing, “Love you forever,” a sentiment that resonated deeply with her followers and loved ones.

In the wake of her death, Jeff Nippard’s team has requested privacy as they navigate this tragic loss. Details remain unconfirmed regarding the exact cause of Buttermore’s death, which has yet to be announced. The community is mourning the loss of a person who inspired many through her work and her personal journey.

Buttermore’s legacy is not only defined by her research and social media presence but also by her ability to connect with people on a personal level. Her work in cancer research, particularly in ovarian cancer, has the potential to save lives, and her influence as a fitness advocate has encouraged countless individuals to pursue healthier lifestyles.

As the world remembers Stephanie Buttermore, her contributions to both science and fitness will continue to inspire future generations. The impact she made during her life will not be forgotten, and her story serves as a reminder of the importance of mental health and the pursuit of one’s passions.

The post Stephanie buttermore appeared first on News Casino.

Guardant Health, a leading biotechnology firm, is at the forefront of innovation in cancer diagnostics and precision medicine. With the increasing prevalence of cancer globally, the need for accurate and non-invasive diagnostic tools has never been more critical. Guardant Health seeks to address this need through its groundbreaking blood tests that help in early cancer detection, treatment selection, and monitoring of patients.

Recent Developments

In October 2023, Guardant Health made headlines when it announced the success of its latest clinical studies on the Guardant Test, a liquid biopsy that uses cutting-edge next-generation sequencing (NGS) technology. This test can detect multiple types of cancer simply through a blood sample, making it a game-changer in oncology. According to the findings published in a peer-reviewed journal, the Guardant Test demonstrated accuracy rates exceeding 90% in identifying cancer at an early stage.

Moreover, Guardant Health has recently entered into collaborations with several healthcare institutions and oncologists to facilitate the integration of their diagnostic solutions into routine clinical practice. These partnerships aim to enhance patient access to timely diagnostic information and provide tailored treatment options based on genetic profiles.

Impact on Patients and Healthcare

The impact of Guardant Health’s advancements is significant. Non-invasive blood tests reduce the need for more invasive procedures such as biopsies, which can be uncomfortable and carry risks. For patients, this means added convenience and peace of mind, while healthcare providers can make more informed decisions on treatment plans based on comprehensive genetic insights.

Looking Ahead

As Guardant Health continues to evolve, it remains committed to expanding its range of diagnostic products and services. The company’s ongoing research and development aim to cover even more cancer types and improve detection capabilities. Forecasts suggest that the demand for liquid biopsies and precision medicine will grow significantly in the coming years, positioning Guardant Health as a key player in this dynamic market.

Conclusion

In conclusion, Guardant Health is revolutionising cancer care through its innovative diagnostic technologies. As the company continues to make strides in research and clinical applications, the potential for enhanced patient outcomes and more personalised treatment strategies expands, marking a significant turning point in the fight against cancer.

The post Guardant Health: Pioneering Cancer Diagnostics appeared first on News Casino.